PLEK2 and neoplasm: PLEK2 has been reported to be highly expressed in several tumor types and promotes cancer progression and metastasis, including breast cancer (9), gastric cancer (10), prostate cancer (11), gallbladder cancer (12), and non-small-cell lung cancer (13).